The Medacta International GMK Sphere Cementless Post-Marketing Surveillance Study
NCT ID: NCT05003414
Last Updated: 2025-09-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
200 participants
OBSERVATIONAL
2020-01-14
2032-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Medacta International GMK Sphere Post-Marketing Surveillance Study
NCT02199600
The Medacta GMK SpheriKA Post-Marketing Surveillance Study
NCT05459948
Multicentre GMK UNI Anatomical Cementless Study - FR
NCT06715917
Medacta GMK Sphere® Multicenter Post-Market Outcomes Study
NCT02501733
A Post-Market Retrospective Study on Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis
NCT02912351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GMK Sphere cementless Knee Replacement
Performance of Total Knee Arthroplasty (TKA) with GMK Sphere cementless Knee Replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients between the age of 18 and 80 at the time of consent
* Listed for total knee replacement surgery.
* Patients who are willing and able to give informed written consent
Exclusion Criteria
* Muscular loss, neuromuscular disease or vascular deficiency of the affected limb, making the operation unjustifiable
* Severe instability secondary to advance destruction of condralar structures or loss of integrity of the medial or lateral ligament
* Those whose prospects for a recovery to independent mobility would be compromised by known coexistent, medical problems
* Patient whose BMI exceeds 40
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medacta International SA
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emmanuel Marchetti, MD
Role: PRINCIPAL_INVESTIGATOR
Clinique Saint Vincent de Paul
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Saint Vincent de Paul
Bourgoin, , France
Clinique du Parc
Caen, , France
Hôpitaux Civils de Colmar
Colmar, , France
Clinique des Acacias
Cucq, , France
Hôpital de la Tour
Meyrin, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P02.014.26
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.